azacitidine has been researched along with Anemia, Cooley's in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, HK; DU, L; Feng, XQ; Gao, Y; Huang, JX; Lan, FF; Li, TL; Liu, SS; Mao, CX; Meng, FJ; Nie, SM; Qin, DQ; Wang, JC; Yan, XS; Yang, Q; Yao, CZ; Yuan, TL | 1 |
| Breda, L; Gambari, R; Rivella, S; Zuccato, C | 1 |
| Fathallah, H | 1 |
| Berenson, RJ; Castaneda, SA; Chui, DH; Faller, DV; Fucharoen, S; Perrine, SP; Siritanaratku, N | 1 |
| Kim, HY; Kuypers, FA; Kwiatkowski, J; Olivieri, NF; Saunthararajah, Y; Thayalasuthan, V; Trachtenberg, FL; Vichinsky, EP; Ware, RE | 1 |
| Cappellini, MD; Musallam, KM; Sankaran, VG; Taher, AT | 1 |
| Cao, H | 1 |
| Lowrey, CH; Nienhuis, AW | 1 |
| Fibach, E; Prasanna, P; Rodgers, GP; Samid, D | 1 |
| Olivieri, NF | 1 |
| Pearson, HA | 1 |
| Rodgers, GP; Saunthararajah, Y | 1 |
5 review(s) available for azacitidine and Anemia, Cooley's
| Article | Year |
|---|---|
Clinical experience with fetal hemoglobin induction therapy in patients with β-thalassemia.
Topics: Anemia, Sickle Cell; Antisickling Agents; Azacitidine; beta-Thalassemia; DNA Methylation; Fetal Hemoglobin; Humans; Hydroxyurea; Professional Practice; Treatment Outcome; Up-Regulation | 2013 |
Pharmacological induction of fetal hemoglobin synthesis using histone deacetylase inhibitors.
Topics: Anemia, Sickle Cell; Azacitidine; beta-Thalassemia; Enzyme Inhibitors; Fetal Hemoglobin; Histone Deacetylase Inhibitors; Humans; Hydroxyurea | 2004 |
Reactivation of fetal hemoglobin in patients with beta-thalassemia.
Topics: Azacitidine; beta-Thalassemia; Butyrates; Butyric Acid; Erythropoietin; Fetal Hemoglobin; Homozygote; Humans; Hydroxyurea; Treatment Outcome | 1996 |
Pharmacologic manipulation of fetal hemoglobin levels in sickle cell diseases and thalassemia: promise and reality.
Topics: Anemia, Sickle Cell; Antineoplastic Agents; Antisickling Agents; Azacitidine; beta-Thalassemia; Erythropoietin; Fetal Hemoglobin; Humans; Hydroxyurea; Phenylbutyrates | 1996 |
Advances in experimental treatment of beta-thalassaemia.
Topics: Azacitidine; beta-Thalassemia; Drug Therapy, Combination; Erythropoietin; Histone Deacetylase Inhibitors; Humans; Hydroxyurea; Iron Chelating Agents | 2001 |
7 other study(ies) available for azacitidine and Anemia, Cooley's
| Article | Year |
|---|---|
Topics: Azacitidine; beta-Globins; beta-Thalassemia; DNA Mutational Analysis; Female; Heterozygote; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Phenotype; Pregnancy; Retrospective Studies; Risk Factors; Silent Mutation; Treatment Outcome | 2020 |
Combining gene therapy and fetal hemoglobin induction for treatment of β-thalassemia.
Topics: Antisickling Agents; Azacitidine; beta-Globins; beta-Thalassemia; Decitabine; Fetal Hemoglobin; Genetic Therapy; Genetic Vectors; Humans; Hydroxyurea; Lentivirus; Retroviridae; Thalidomide | 2013 |
DNA hypomethylation therapies and hemoglobin disorders. [An interview with Hassana Fathallah by H&O].
Topics: Anemia, Sickle Cell; Antineoplastic Agents; Azacitidine; beta-Thalassemia; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Enzyme Inhibitors; Fetal Hemoglobin; Histone Acetyltransferases; Humans; Hydroxyurea | 2008 |
Fetal globin gene inducers: novel agents and new potential.
Topics: alpha-Globins; Antimetabolites, Antineoplastic; Azacitidine; beta-Thalassemia; Butyrates; Clinical Trials as Topic; Decitabine; Fetal Hemoglobin; Humans; Mutation; Quantitative Trait Loci; Transcriptional Activation | 2010 |
A pilot study of subcutaneous decitabine in β-thalassemia intermedia.
Topics: Adult; Antimetabolites, Antineoplastic; Azacitidine; beta-Thalassemia; Cell Differentiation; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Erythrocytes; Female; gamma-Globins; Gene Expression Regulation; Hemoglobins; Humans; Injections, Subcutaneous; Male; Middle Aged; Pilot Projects; Prognosis; Young Adult | 2011 |
Brief report: treatment with azacitidine of patients with end-stage beta-thalassemia.
Topics: Adult; Azacitidine; beta-Thalassemia; Female; Ferritins; Hemoglobins; Humans; Male; Middle Aged | 1993 |
Enhanced fetal hemoglobin production by phenylacetate and 4-phenylbutyrate in erythroid precursors derived from normal donors and patients with sickle cell anemia and beta-thalassemia.
Topics: Anemia, Sickle Cell; Azacitidine; beta-Thalassemia; Blotting, Northern; Butyrates; Butyric Acid; Cell Division; Cells, Cultured; DNA Probes; Erythrocytes; Fetal Hemoglobin; Hematopoietic Stem Cells; Humans; Hydroxyurea; Kinetics; Phenylacetates; Phenylbutyrates; Reference Values | 1993 |